Report
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members
, 
, , , , , , , , , , , , , , , , , , , & show all
Sherry H. YehBiochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-2015-4563View further author information
https://orcid.org/0000-0002-2015-4563View further author information, Shravan MadireddiCancer Immunology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-7069-1252View further author information
https://orcid.org/0000-0002-7069-1252View further author information, Wadim L. MatochkoDepartments of Antibody Engineering, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0001-7387-9106View further author information
https://orcid.org/0000-0001-7387-9106View further author information, , , Mark UltschStructural Biology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-8290-5908View further author information
https://orcid.org/0000-0002-8290-5908View further author information, Gladys De Leon BoenigStructural Biology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-8314-1188View further author information
https://orcid.org/0000-0002-8314-1188View further author information, , , Suzie J. ScalesMolecular Biology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0003-2544-0283View further author information
https://orcid.org/0000-0003-2544-0283View further author information, , , , , Scot MarstersCancer Immunology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-8517-0994View further author information
https://orcid.org/0000-0002-8517-0994View further author information, , , , Rafael CubasTranslational Oncology, Genentech Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-3450-9054View further author information
https://orcid.org/0000-0002-3450-9054View further author information, & show all